Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Invesco Private Capital
AddedMar 19, 2024
UpdatedJul 22, 2026
Invesco Private Capital

Invesco Private Capital

Operating

Global investment management firm offering diverse funds.

Location
Atlanta, GA, US
Founded
1981
Firm
Compare
Portfolio
Fundraising
Employees
News

Investments

Mynd Management
Mynd Management

Total Raised

$204.9M

Rounds

8

Series Unknown$30MJuly 2023
Series Unknown$40MJune 2021
Flowcarbon
Flowcarbon

Total Raised

$71.6M

Rounds

2

Series A$70MMay 2022
Copper Banking
Copper Banking

Total Raised

$42.3M

Rounds

3

Series A$29MApril 2022
Capchase
Capchase

Total Raised

$949.6M

Rounds

8

Series B$80MMarch 2022
Hum Capital
Hum Capital

Total Raised

$35M

Rounds

4

Series A$12MNovember 2021
Brii Biosciences
Brii Biosciences
Public

Total Raised

$415M

Rounds

3

Series C$155MMarch 2021
Nubank
Nubank

Total Raised

$4.5B

Rounds

16

Series G$400MJanuary 2021
Alfred
Alfred

Total Raised

$144.8M

Rounds

9

Series B$40MMay 2018
Vedanta Biosciences
Vedanta Biosciences

Total Raised

$433.1M

Rounds

15

Private Equity$50MJune 2016
SciFluor Life Sciences
SciFluor Life Sciences

Total Raised

$35M

Rounds

2

Series B$30MApril 2015
SpaceX
SpaceX

Total Raised

$9.8B

Rounds

33

Series G$1BJanuary 2015
Maxwest Environmental Systems
Maxwest Environmental Systems

Total Raised

$42.5M

Rounds

2

Series C$32.5MApril 2011
Chelsio Communications
Chelsio Communications
Acquired

Total Raised

$115M

Rounds

7

Series F$17MNovember 2009
Series E$25MJanuary 2008
NovaSys Health
NovaSys Health

Total Raised

$49.5M

Rounds

1

Series Unknown$49.5MMay 2008
Novasys Medical
Novasys Medical
Acquired

Total Raised

$144.9M

Rounds

7

Series D$49.5MMay 2008
Point Biomedical
Point Biomedical

Total Raised

$58.1M

Rounds

4

Private Equity$25MJanuary 2008
Genband
Genband
Acquired

Total Raised

$831.5M

Rounds

16

Series Unknown$18MMarch 2005
Series D$66MJuly 2001
Starvox
Starvox
Acquired

Total Raised

$46.5M

Rounds

4

Series D$10MDecember 2001
Ishoni Networks
Ishoni Networks
Acquired

Total Raised

$77.5M

Rounds

4

Series C$35MMarch 2001
Series B$9MMarch 2000
Calient Technologies
Calient Technologies

Total Raised

$437.1M

Rounds

16

Series C$195MJanuary 2001
Endgate
Endgate

Total Raised

$25M

Rounds

1

Series Unknown$25MMarch 2000